PROSTATE CANCER with the support of Bayer

13 Oct 2023
09:40

PROSTATE CANCER with the support of Bayer

  • Which second generation hormonal treatment to choose in mHSPC? A personalized approach
  • Metachronous low volume mHSPC: intermitent, doublet or triplet therapy?
  • Strategy to delay systemic treatments with SBRT in prostate cancer